Colitis

Scientists discover pain receptor on T-cells

Researchers at University of California, San Diego School of Medicine have discovered that T-cells – a type of white blood cell that learns to recognize and attack microbial pathogens – are activated by a pain receptor.

Oct 05, 2014
popularity 5 / 5 (11) | comments 1

Added benefit of vedolizumab is not proven

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Oct 23, 2014
popularity not rated yet | comments 0

In medicine, colitis (pl. colitides) refers to an inflammation of the colon and is often used to describe an inflammation of the large intestine (colon, caecum and rectum).

Colitides may be acute and self-limited or chronic, i.e. persistent, and broadly fit into the category of digestive diseases.

In a medical context, the label colitis (without qualification) is used if:

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

New compounds reduce debilitating inflammation

Six Case Western Reserve scientists are part of an international team that has discovered two compounds that show promise in decreasing inflammation associated with diseases such as ulcerative colitis, arthritis and multiple ...